| Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection X Chai, L Hu, Y Zhang, W Han, Z Lu, A Ke, J Zhou, G Shi, N Fang, J Fan, ... biorxiv, 2020.02. 03.931766, 2020 | 1066 | 2020 |
| Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition) J Zhou, H Sun, Z Wang, W Cong, J Wang, M Zeng, W Zhou, P Bie, L Liu, ... Liver cancer 9 (6), 682-720, 2020 | 536 | 2020 |
| Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer D Wu, D Hu, H Chen, G Shi, IS Fetahu, F Wu, K Rabidou, R Fang, L Tan, ... Nature 559 (7715), 637-641, 2018 | 383 | 2018 |
| Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma PF Zhang, C Gao, XY Huang, JC Lu, XJ Guo, GM Shi, JB Cai, AW Ke Molecular cancer 19, 1-15, 2020 | 352 | 2020 |
| Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis YH Shi, ZB Ding, J Zhou, BO Hui, GM Shi, AW Ke, XY Wang, Z Dai, ... Autophagy 7 (10), 1159-1172, 2011 | 348 | 2011 |
| Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma ZB Ding, YH Shi, J Zhou, SJ Qiu, Y Xu, Z Dai, GM Shi, XY Wang, AW Ke, ... Cancer research 68 (22), 9167-9175, 2008 | 320 | 2008 |
| High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma XR Yang, Y Xu, B Yu, J Zhou, SJ Qiu, GM Shi, BH Zhang, WZ Wu, YH Shi, ... Gut 59 (7), 953-962, 2010 | 304 | 2010 |
| Role of overexpression of CD151 and/or c‐Met in predicting prognosis of hepatocellular carcinoma AW Ke, GM Shi, J Zhou, FZ Wu, ZB Ding, MY Hu, Y Xu, ZJ Song, ZJ Wang, ... Hepatology 49 (2), 491-503, 2009 | 278 | 2009 |
| Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling PF Zhang, KS Li, YH Shen, PT Gao, ZR Dong, JB Cai, C Zhang, ... Cell death & disease 7 (4), e2201-e2201, 2016 | 223 | 2016 |
| Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials GM Shi, Y Xu, J Fan, J Zhou, XR Yang, SJ Qiu, Y Liao, WZ Wu, Y Ji, ... Journal of cancer research and clinical oncology 134, 1155-1163, 2008 | 218 | 2008 |
| Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma J Cai, L Chen, Z Zhang, X Zhang, X Lu, W Liu, G Shi, Y Ge, P Gao, Y Yang, ... Gut 68 (12), 2195-2205, 2019 | 214 | 2019 |
| CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial–mesenchymal transition in HCC cells AW Ke, GM Shi, J Zhou, XY Huang, YH Shi, ZB Ding, XY Wang, ... Gastroenterology 140 (5), 1629-1641. e15, 2011 | 212 | 2011 |
| Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation ZB Ding, B Hui, YH Shi, J Zhou, YF Peng, CY Gu, H Yang, GM Shi, AW Ke, ... Clinical Cancer Research 17 (19), 6229-6238, 2011 | 204 | 2011 |
| Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma JY Shi, Q Gao, ZC Wang, J Zhou, XY Wang, ZH Min, YH Shi, GM Shi, ... Clinical Cancer Research 19 (21), 5994-6005, 2013 | 200 | 2013 |
| Circular RNA circTRIM33–12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression PF Zhang, CY Wei, XY Huang, R Peng, X Yang, JC Lu, C Zhang, C Gao, ... Molecular cancer 18, 1-15, 2019 | 186 | 2019 |
| αB‐crystallin complexes with 14‐3‐3ζ to induce epithelial‐mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma XY Huang, AW Ke, GM Shi, X Zhang, C Zhang, YH Shi, XY Wang, ... Hepatology 57 (6), 2235-2247, 2013 | 178 | 2013 |
| Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection XR Yang, Y Xu, GM Shi, J Fan, J Zhou, Y Ji, HC Sun, SJ Qiu, B Yu, Q Gao, ... Clinical cancer research 14 (12), 3850-3859, 2008 | 174 | 2008 |
| Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis XY Huang, PF Zhang, CY Wei, R Peng, JC Lu, C Gao, JB Cai, X Yang, ... Molecular cancer 19, 1-18, 2020 | 165 | 2020 |
| CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma Q Gao, YJ Zhao, XY Wang, SJ Qiu, YH Shi, J Sun, Y Yi, JY Shi, GM Shi, ... Cancer research 72 (14), 3546-3556, 2012 | 163 | 2012 |
| Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial–mesenchymal transition K Zhu, Z Dai, Q Pan, Z Wang, GH Yang, L Yu, ZB Ding, GM Shi, AW Ke, ... Clinical cancer research 17 (23), 7294-7302, 2011 | 162 | 2011 |
